Clinical Trial Update: Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TAK-385 for localized prostate cancer. Safety and efficacy results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TAK-385

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13